Policy for Abstracts
Work submitted for presentation should not have been reported previously in an archival scientific publication, either as an article or as an abstract, at the time of submission. Data that has been, or will be, presented at any other meeting before being presented at the 2023 Tandem Meetings of ASTCT and CIBMTR, will not be accepted for presentation.
Due to the overlap in abstract submission and notification timelines for the 2022 ASH Annual Meeting, data submitted to the 2022 ASH Annual Meeting is acceptable for submission to the 2023 Tandem Meetings of ASTCT and CIBMTR. However, abstracts that are accepted and presented at other meetings, including ASH 2022, will not be considered for Tandem Best Abstract Awards. All submitted abstracts will be reviewed by the Tandem Meetings Scientific Organizing Committee, which has discretion to decide if an abstract presented at the 2022 ASH Meeting will be eligible for presentation at the 2023 Tandem Meetings.
Conference Registration Fee
Abstract presenting authors will be eligible for the Early Registration Rate even after Standard and On-Site registration rates apply.
Abstract Submission Fee
There is a $50 non-refundable abstract submission fee.
Abstract data/research must apply to one of the following categories:
Nursing Track Abstract Categories
Responsibility of Abstract Authors
The first author listed for each abstract serves as the Presenting Author and is the primary contact for all correspondence regarding the abstract.
The Presenting Author is responsible for the following:
Each abstract author agrees and certifies that they:
Abstracts are peer reviewed on their scientific merits and according to subject category. Individuals submitting abstracts must indicate the appropriate review category. Abstracts may be re-categorized to a more appropriate category based on guidance from the Tandem Meetings Co-Chairs. The ASTCT, CIBMTR and Tandem Meetings of ASTCT and CIBMTR reserve the right to make minor editorial grammatical/spelling changes if required for clarity of presentation.
All changes/edits to submitted abstracts are strictly the responsibility of the first author and must be conducted within the confines of the abstract submission portal. Requests for assistance in accessing abstracts to allow for modifications, should be submitted in writing to firstname.lastname@example.org.
Abstract withdrawals can be made within the submission system by the first author, no later than Friday, October 21, 2022 at 11:59 pm PT.
Abstract withdrawal requests after Friday, October 21, 2022 at 11:59 pm PT must be made, in writing only, to email@example.com. ASTCT and CIBMTR Staff cannot fulfill any withdrawal requests by phone. Accepted abstracts that remain in the submission system on November 10, 2022 may be published online and in ASTCT's journal, Transplantation and Cellular Therapy, as submitted.
Any submitted abstract deemed incomplete within the submission system on September 24, 2022 at 12:01 am PT will be eliminated without further notification prior to abstracts being distributed to the 2022 Tandem Meetings abstract review team.
The submission of late-breaking abstracts will be allowed from November 22, 2022 – December 7, 2022 at 11:59 pm PT.
Late-breaking abstract authors must complete a request for information to explain the need for submission during the late-breaking abstract submission process, which will be shared with the abstract reviewers and program Co-Chairs.
Abstracts submitted for presentation will be embargoed by the author(s) and the 2023 Tandem Meetings, upon submission.
Abstracts submitted for presentation to the 2023 Tandem Meetings will be embargoed by the author(s) and the 2023 Tandem Meetings, upon submission. The embargo will be lifted and abstracts will be made available for viewing on January 13, 2023.
Authors assign copyright of the abstract to ASTCT upon submission, unless one of the authors is a U.S. Federal employee. This means that the identical abstract may not be republished or submitted to another meeting; however, Elsevier may grant permission for reuse of abstract content on behalf of ASTCT. You can request to re-use an abstract by clicking here.